or Try an Advanced Search...

    Technical Analysis for TCRT - Alaunos Therapeutics, Inc.

    Grade Last Price % Change Price Change
    F 2.19 2.82% 0.06
    TCRT closed up 0.95 percent on Wednesday, November 20, 2024, on 69 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Up
    Historical TCRT trend table...
    Date Alert Name Type % Chg
    Crossed Above 20 DMA Bullish 2.82%
    Bollinger Band Squeeze Range Contraction 2.82%
    Doji - Bullish? Reversal 2.82%
    BB Squeeze + Upper Band Touch Range Contraction 2.82%
    BB Squeeze Started Range Contraction 2.82%
    Outside Day Range Expansion 2.82%
    Upper Bollinger Band Touch Strength 2.82%
    Oversold Stochastic Weakness 2.82%
    20 DMA Resistance Bearish 3.79%
    NR7 Range Contraction 3.79%
    Older End-of-Day Signals for TCRT ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakout about 1 hour ago
    10 DMA Resistance about 1 hour ago
    Up 5% about 1 hour ago
    Up 3% about 1 hour ago
    Up 2% about 1 hour ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    TCRT Chart by TradingView
    Basic chart:

    Profile

    Alaunos is a clinical-stage oncology-focused cell therapy company, focused on developing T-cell receptor (TCR) therapies based on its proprietary, non-viral Sleeping Beauty gene transfer platform and its unique cancer mutation hotspot TCR library, targeting common tumor-related mutations in key oncogenic genes including KRAS, TP53 and EGFR. The Company has clinical and strategic collaborations with The University of Texas MD Anderson Cancer Center and the National Cancer Institute.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Cancer Cell Therapy Epidermal Growth Factor Receptor Oncogenes National Cancer Institute P53 Ras Gtpase Tumor Suppressor Genes University Of Texas Md Anderson Cancer Center

    Is TCRT a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 11 Alaunos Therapeutics Ends Licensing Deal, Reassesses Strategy
    See more TCRT news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 32.85
    52 Week Low 1.95
    Average Volume 20,756
    200-Day Moving Average 8.73
    50-Day Moving Average 2.45
    20-Day Moving Average 2.13
    10-Day Moving Average 2.18
    Average True Range 0.22
    RSI (14) 46.24
    ADX 17.15
    +DI 31.44
    -DI 18.29
    Chandelier Exit (Long, 3 ATRs) 2.19
    Chandelier Exit (Short, 3 ATRs) 2.62
    Upper Bollinger Bands 2.38
    Lower Bollinger Band 1.88
    Percent B (%b) 0.5
    BandWidth 23.54
    MACD Line -0.06
    MACD Signal Line -0.09
    MACD Histogram 0.0244
    Fundamentals Value
    Market Cap 34.17 Million
    Num Shares 16 Million
    EPS -2.25
    Price-to-Earnings (P/E) Ratio -0.95
    Price-to-Sales 2277.94
    Price-to-Book 2.70
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.60
    Resistance 3 (R3) 2.63 2.50 2.52
    Resistance 2 (R2) 2.50 2.39 2.49 2.49
    Resistance 1 (R1) 2.32 2.31 2.26 2.29 2.47
    Pivot Point 2.19 2.19 2.16 2.18 2.19
    Support 1 (S1) 2.01 2.07 1.94 1.97 1.79
    Support 2 (S2) 1.88 2.00 1.87 1.77
    Support 3 (S3) 1.70 1.88 1.74
    Support 4 (S4) 1.66